Market Research Logo

Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review

Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology and generic product development. It operates sales network in Hungary, Central Eastern Europe and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Richter is headquartered in Budapest, Hungary.

Richter Gedeon Nyrt Key Recent Developments

Oct 09,2018: Gedeon Richter Plc.: Cariprazine Shows Favorable Safety Parameters and Efficacy in Reducing Schizophrenia Negative Symptoms Compared to Aripiprazole
Sep 18,2018: Announcements Richter signed a license and distribution agreement to enhance its fertility portfolio[TDN Alerts : Others]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company
Richter Gedeon Nyrt - Key Facts
Richter Gedeon Nyrt - Key Employees
Richter Gedeon Nyrt - Key Employee Biographies
Richter Gedeon Nyrt - Major Products and Services
Richter Gedeon Nyrt - History
Richter Gedeon Nyrt - Company Statement
Richter Gedeon Nyrt - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Richter Gedeon Nyrt - Business Description
Business Segment: Others
Business Segment: Pharmaceuticals
Key Stats
Business Segment: Wholesale and Retail
Key Stats
Geographical Segment: China
Geographical Segment: CIS
Geographical Segment: Europe
Geographical Segment: Hungary
Geographical Segment: Latin America
Geographical Segment: ROW
Geographical Segment: USA
R&D Overview
Richter Gedeon Nyrt - Corporate Strategy
Richter Gedeon Nyrt - SWOT Analysis
SWOT Analysis - Overview
Richter Gedeon Nyrt - Strengths
Richter Gedeon Nyrt - Weaknesses
Richter Gedeon Nyrt - Opportunities
Richter Gedeon Nyrt - Threats
Richter Gedeon Nyrt - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Richter Gedeon Nyrt, Recent Deals Summary
Section 5 – Appendix
Ratio Definitions
About GlobalData
Contact Us
List of Tables
Richter Gedeon Nyrt, Key Facts
Richter Gedeon Nyrt, Key Employees
Richter Gedeon Nyrt, Key Employee Biographies
Richter Gedeon Nyrt, Major Products and Services
Richter Gedeon Nyrt, History
Richter Gedeon Nyrt, Other Locations
Richter Gedeon Nyrt, Subsidiaries
Richter Gedeon Nyrt, Joint Venture
Richter Gedeon Nyrt, Key Competitors
Richter Gedeon Nyrt, Ratios based on current share price
Richter Gedeon Nyrt, Annual Ratios
Richter Gedeon Nyrt, Annual Ratios (Cont...1)
Richter Gedeon Nyrt, Annual Ratios (Cont...2)
Richter Gedeon Nyrt, Interim Ratios
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Richter Gedeon Nyrt, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Richter Gedeon Nyrt, Performance Chart (2013 - 2017)
Richter Gedeon Nyrt, Ratio Charts
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report